STING1 and hepatocellular carcinoma: We successfully constructed a bimetallic Ca/Zn nanoagonist (PZH/Zn@CaNA), which effectively suppressed tumor activity and remoulded the iMWA‐associated immunosuppressive HCC microenvironment by dual‐mediating inflammatory necrosis and STING pathways.